Last updated 2026-08-24
- Raised $100M Series C led by 5AM Ventures, May 2024
- Raised $165M Series B led by Khosla Ventures, Feb 2020
- Raised $50M Series A led by Tencent, Aug 2017
Total raised
$315.0M
Stage
—
Founded
2014
Headcount
—
HQ
Redwood City, United States
Sector
Life Sciences
About
Karius is a clinical metagenomics company focused on elevating patient care through microbial insights. It is committed to advancing diagnostic science and technology to optimize the diagnosis and treatment of infectious diseases. Through the use of genomics and AI, Karius delivers unprecedented diagnostic insight detecting microbial cell-free DNA circulating in the body to assist physicians to make rapid treatment decisions. Karius was founded in 2014 and is built on intellectual property developed at Stanford University. Headquartered in Redwood City, California, the company operates a CLIA-certified, CAP-accredited, and ISO 15189-accredited laboratory to perform high-complexity clinical laboratory testing. Karius metagenomic testing solutions are being utilized by 600+ leading hospitals and transplant centers throughout the US and over 100,000 patient samples tested.
Funding history · 5 rounds · $315.0M total
2024-05
C Round
$100.0M
★ 5AM Ventures★ Khosla Ventures★ Gilde Healthcare★ General Catalyst★ Seventure Partners★ SoftBank Vision Fund 2★ Blue Water Life Sciences★ HBM Healthcare InvestmentsVali BarsanAndrew BoothAndy CoravosNanoDimensionYsios CapitalPareto HoldingsWaycross VenturesWorklife VenturesCoalition OperatorsInnovation EndeavorsClaire Hughes Johnson
2020-02
B Round
$165.0M
★ Khosla Ventures★ General Catalyst★ SoftBank Vision Fund 2★ HBM Healthcare Investments★ Lightspeed Venture PartnersAaron LevieDrew HoustonMarc BenioffHBM MedfocusShishir MehrotraFounder Collective
2018-11
Debt Financing
Undisclosed
2017-08
A Round
$50.0M
★ Tencent★ Spectrum 28★ Khosla Ventures★ Innovation Endeavors★ Lightspeed Venture Partners★ Data Collective (DCVC)Data Collective
2014-09
Seed
Undisclosed
Q&A
- What is Karius Inc.'s primary focus?
- Karius Inc. is a life sciences company focused on generating genomic insights for infectious diseases using a non-invasive blood test.
- When was Karius Inc. founded?
- Karius Inc. was founded in 2014.
- What is the total amount of funding Karius Inc. has raised to date?
- Karius Inc. has raised a total of $315,000,000 USD.
- When did Karius Inc. complete its Series C funding round and who were the lead investors?
- In May 2024, Karius Inc. completed a Series C funding round, raising $100,000,000. The round was co-led by 5AM Ventures and Khosla Ventures.
- Who are the co-founders of Karius Inc.?
- The co-founders of Karius Inc. are Tim Blauwkamp, Mickey Kertesz, and Steve Quake.
- What is Karius Inc.'s core technology?
- Karius Inc.'s core technology involves genomic analysis, artificial intelligence, and microbial cell-free DNA (mcfDNA) detection.
- Who is the current CEO of Karius Inc.?
- Alec Ford is the CEO of Karius Inc.
- When did Karius Inc. complete its Series B funding round and who were the lead investors?
- In February 2020, Karius Inc. completed a Series B funding round, raising $165,000,000. The round was led by Khosla Ventures and General Catalyst.
Team · 8
Tim Blauwkamp
Founder · Chief Scientific Officer, Co-founder
Alec Ford
Chief Executive Officer
Sivan Bercovici
Chief Technology and Business Officer
Bradley Perkins
Chief Medical Officer
Steve Malaska
Chief Legal Officer
Bill Quirk
Chief Financial Officer
Mark Aguillard
Chief Commercial Officer
Stacy Aurora
Chief People Officer
Sectors & technology
Primary sector
Life Sciences
Technologies
Target customers
Business model
B2BDiagnostic Testing Service
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | kariusdx.com |
|---|
Identifiers & details
| Legal name | Karius Inc. |
|---|---|
| Founded | 2014 |
Radar intelligence
Open jobs — lever
| Total open | 12 |
|---|---|
| Remote | 8 |
| By department | Clinical Affairs (3), Customer Success (1), Sales (4), Molecular Biology (1), CLIA Production Lab (2), General Opportunities (1) |
| By location | Redwood City, CA (Hybrid) or Remote (USA) (4), Remote (United States) (4), Redwood City, CA (3), Seattle, WA (1) |
| Title | Location | Department |
|---|---|---|
| Clinical Trial Associate | Redwood City, CA (Hybrid) or Remote (USA) | Clinical Affairs |
| Clinical Research Associate II (East Coast or Midwest) | Remote (United States) | Clinical Affairs |
| Customer Success Representative I | Redwood City, CA (Hybrid) or Remote (USA) | Customer Success |
| Biostatistician II | Redwood City, CA (Hybrid) or Remote (USA) | Clinical Affairs |
| Medical Science Liaison | Remote (United States) | Sales |
| Clinical Sales Manager | Remote (United States) | Sales |
| Senior Research Associate | Redwood City, CA | Molecular Biology |
| Director, Health Systems | Remote (United States) | Sales |
| Clinical Laboratory Associate II | Redwood City, CA | CLIA Production Lab |
| Sr. Clinical Laboratory Associate | Redwood City, CA | CLIA Production Lab |
| Clinical Sales Manager (Seattle) | Seattle, WA | Sales |
| General Opportunities | Redwood City, CA (Hybrid) or Remote (USA) | General Opportunities |
Patents
| EPO | 42 |
|---|
GitHub
| Top repos | shippo-csharp-client, tf_aws_elasticsearch, nextflow, tf_aws_elasticache_redis, terraform-elasticache |
|---|